Our previous findings with HAMLET have demonstrated a pronounced different effect on the BRAF mutant cell line than others, revealing its dose-dependent cytotoxic effects on CRC cells, predominantly leading to necrotic death, and altered mitochondrial functions in specific cell lines [16]. This evidence concerns the gene BRAF and colorectal carcinoma.